Liminatus Pharma Inc. has settled claims it blocked a brokerage’s exercise of warrants after going public, satisfying a default judgment against the biotech company, according to a court filing Friday.
Broker-dealer Clear Street LLC told the US District Court for the Southern District of New York that it entered into a settlement with Liminatus “on mutually agreed terms.” Clear Street acknowledged “full and complete satisfaction” of the judgment, but Liminatus and an attorney for the brokerage didn’t immediately respond to inquiries as to whether they settled for the roughly $7.6 million plus interest specified in the September 2025 default judgment. ...